首页|β-内酰胺酶抑制剂关键中间体的微通道技术合成

β-内酰胺酶抑制剂关键中间体的微通道技术合成

扫码查看
为了优化二氮杂双环辛烷(DBO)类新型β-内酰胺酶抑制剂的关键中间体(2S,5R)-6-苄氧基-7-氧代-1,6-二氮杂双环[3.2.1]辛烷-2-羧酸(Ⅰ)的合成工艺,采用微通道技术,通过对反应溶剂、温度、停留时间和碱的优化,以加快反应速率,提高反应产率.结果表明:采用连续流微通道技术,以(2S,5R)-6-苄氧基-7-氧代-1,6-二氮杂双环[3.2.1]辛烷-2-羧酸苄酯(Ⅱ)为原料,在氢氧化锂的丙酮水溶液中,温度45℃,反应时间20 min,水解制备得到DBO类新型β-内酰胺酶抑制剂的关键中间体(Ⅰ),经氢谱、碳谱、高分辨质谱鉴定,产物与目标化合物一致,目标产物的收率可达95%.该微通道合成方法显著加快反应速率的同时提高了反应收率,对DBO类新型β-内酰胺酶抑制剂的工业化生产具有应用前景.
Synthesis of key intermediates of β-lactamase inhibitors by microchannel technology
Microchannel technology was used to improve the synthesis efficiency of(2S,5R)-6-benzyloxy-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid(Ⅰ),a key intermediate of novel β-lactamase inhibitors based on diazabicyclooctane(DBO).Through the investigation of solvent,temperature,residence time and base,the process conditions were optimized.The results show that the hydrolysis of(2S,5R)-6-benzyloxy-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylic acid benzyl ester(Ⅱ)in microchannel reactor is best conducted with acetone as a solvent and lithium hydroxide as a base at 45℃for 20 min.The product was identified by 1H nuclear magnetic resonance spectroscopy,13C nuclear magnetic resonance spectroscopy and high resolution mass spectroscopy.The key intermediate(Ⅰ)is obtained in 95%yield.Thus this technology significantly increases the rate and yield of this reaction and makes it feasible to industrial production.

DBO compoundβ-lactamase inhibitorscontinuous-flow microchannel technologyhydrolysis

赵晨熙、王池、董江湖、张丹华、邓鑫浩、陈尧、严琼姣

展开 >

武汉工程大学药物研究院,湖北 武汉 430205

DBO类化合物 β-内酰胺酶抑制剂 连续流微通道技术 水解

湖北省重点研发计划项目

2023BCB055

2024

武汉工程大学学报
武汉工程大学

武汉工程大学学报

影响因子:0.463
ISSN:1674-2869
年,卷(期):2024.46(1)
  • 15